Were You Aware ...?
Published: October 15, 2020
This content is for informational purposes only. This should not be construed as solicitation. The general public should consult their financial advisor for additional information related to investment decisions.
The pandemic continues to unexpectedly shift supply and demand curves, the latest observation coming from the pet care industry

Wells Fargo Advisors: You can find a CAR approved version of last Thursday’s quarterly newsletter under the "Other" section of the "Media & Education" page. The CAR ref number is CAR-1020-01326.

Beginners Series Webinar: Join us on Friday, October 16th, at 2 PM (ET) for our NDW Beginners Series Webinar. This week's topic is Navigating the Dynamic Asset Level Investing (DALI) & Asset Class Group Scores (ACGS) pages. Register here.


The pandemic continues to unexpectedly shift supply and demand curves, the latest observation coming from the pet care industry. With individuals being encouraged to spend greater amounts of time at home, pet ownership has climbed, along with demand for related services offered by animal-health companies (Source: wsj.com). Take for example a name like Freshpet FRPT, an American business that manufactures refrigerated food and treats for animals, their stock is up over 100% this year (through 10/14). Another example is a company called IDEXX Laboratories IDXX that develops, manufactures, and distributes products to the animal veterinary markets, their stock is up over 60% this year. Both of these names returned to strong attribute territory (technical attribute of 3+) in the middle of March and have not looked back.

FRPT and IDXX are the two largest holdings in the ProShares Pet Care ETF PAWZ, a strategy that stands to benefit from people’s passions for their pets (Source: proshares.com). PAWZ hit a fresh all-time high today (10/15) and carries a stellar 5.96 fund score atop a positive score direction of 0.97, adding technical merit to its thematic strength. Despite the favorable picture, PAWZ is pushing into extended territory so those looking to initiate new long exposure may consider dollar-cost averaging in or entering on a contraction. Initial support is offered at $56.

Back to report

DISCLOSURE

This report is for Internal Use Only and not for distribution to the public. While we make every effort to be free of errors in this report, it contains data obtained from other sources. We believe these sources to be reliable, but we cannot guarantee their accuracy. Investors who use options should read the Options Disclosure Document before making any particular investment decision. Officers or employees of this firm may now or in the future have a position in the stocks mentioned in this report. Dorsey, Wright is a Registered Investment Advisor with the U.S. Securities & Exchange Commission. Copies of Form ADV Part II are available upon request.
Equity prices provided by Thomson-Reuters. Cross Rate prices provided by Tenfore Systems. Option prices provided by OPRA
Copyright © 1995-{ENDYEAR} Dorsey, Wright & Associates, LLC.®
All quotes displayed are delayed 20 minutes
Disclaimer/Terms of Use/Copyright